Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer
NCT ID: NCT02853409
Last Updated: 2018-12-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
628 participants
OBSERVATIONAL
2014-01-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptomatic prostate cancer patients who present symptoms due to prostate cancer disease
* Capacity to comply with the protocol
* Patient with an expected survival \> 12 months
Exclusion Criteria
* Patient with other malignant diseases, apart from prostate cancer
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ipsen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ipsen Medical Director
Role: STUDY_DIRECTOR
Ipsen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Quirón Campo de Gibraltar
Cadiz, , Spain
H. San Juan de Dios
Córdoba, , Spain
Hospital Quiron Vizcaya
Erandio, , Spain
H. Can Misses
Ibiza Town, , Spain
Hospital San Juan de Dios
León, , Spain
H. de Torrelodones
Madrid, , Spain
H. Montepríncipe
Madrid, , Spain
Hospital Quirón San Camilo
Madrid, , Spain
Hospital San Rafael
Madrid, , Spain
Hospital Quirón Marbella
Marbella, , Spain
Hospital Parque San Antonio
Málaga, , Spain
H. Infanta Sofía
San Sebastián de los Reyes, , Spain
Hospital NISA
Seville, , Spain
Hospital Sagrado Corazón
Seville, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A-92-52014-215
Identifier Type: -
Identifier Source: org_study_id